DTP Bid Led by University of Oxford

The University of Oxford is receiving MRC funding to train the next generation of biomedical researchers through a Doctoral Training Partnership. This matters because the UK needs a steady pipeline of skilled scientists to maintain its position as a world leader in medical research. Without structured, high-quality doctoral training programmes, talented graduates may lack the breadth of skills—from experimental design to data analysis and public engagement—needed to tackle complex health challenges. The partnership provides a coordinated framework for postgraduate education that individual departments alone cannot offer. If successful, this training programme will produce PhD graduates equipped to work across academia, industry, and healthcare. These researchers could go on to develop new treatments, improve diagnostic tools, or strengthen public health policy. The impact is indirect but foundational: better-trained scientists mean better science, which ultimately benefits patients and the NHS. This is primarily an education and skills investment rather than a specific research project. It funds people, not experiments. The immediate output is trained researchers, not discoveries. However, similar training partnerships have historically produced scientists who later made breakthroughs in areas from vaccine development to gene therapy.